MedTrace Logo

Family Planning Intentions and Practices Among Women With Poor Obstetric Outcome

NCT02674542 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2019-02-04

No results posted yet for this study

Summary

Women who have experienced a stillbirth or neonatal death are at higher risk of repeated poor neonatal outcomes if they have short interpregnancy intervals. Understanding the attitudes surrounding future fertility and contraception in this population is critical to propose socially and culturally acceptable interventions to address an unmet need for family planning.

Participants: Women who have experienced a stillbirth or early neonatal death will be recruited from the postnatal ward of Bwaila Maternity Hospital in Lilongwe, Malawi.

Procedures (methods): This will be a qualitative study using 20 in-depth interviews and four focus group discussions of up to 10 women each.

Conditions

  • Stillbirth

Interventions

OTHER

In-depth interviews

1. Future family planning intentions and beliefs 2. Family planning experiences and beliefs: 3. Feasibility and acceptability of birth spacing promotion for women who experienced a still birth or early neonatal demise

OTHER

Focus Group

1. Future family planning intentions and beliefs 2. Family planning experiences and beliefs: 3. Feasibility and acceptability of birth spacing promotion for women who have experienced a stillbirth or early neonatal demise

Sponsors & Collaborators

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Dawn Kopp, MD, MPH · UNC-CH

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2015-10-31
Completion
2016-06-30

Countries

  • Malawi

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02674542 on ClinicalTrials.gov